University Hospital Antwerp

General

Total Cases2

Active Cases--

Patents6

CourtsD. Delaware

TypeNPE

Elite Ratings

--

--

--

--

Ratings

Experience

Grade

Trend

DCT

--

--

--

PTAB

--

--

--

CAFC

--

--

--

Analytics

Cases

Litigated Patents

Ratings Trends

Recent Dockets

Entered	Case	Description
08/04/23	Zogenix Inc v. Apotex Inc 1:21-CV-01252 ( D. DE )	ORAL ORDER: The parties have advised that disputes have arisen requiring attention. The Court will hold a discovery conference on 9/1/2023, at 11:00 AM in Courtroom 6A. In preparation for this conference the parties shall follow the Discovery Matters and Disputes procedure as set forth in the Scheduling Order. Ordered by Judge Richard G. Andrews on 8/4/2023. (nms) (Entered: 08/04/2023)
07/25/23	Zogenix Inc v. Apotex Inc 1:21-CV-01252 ( D. DE )	Pro Hac Vice Attorney Zhibin Li for Lupin Ltd. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (jdb) (Entered: 07/25/2023)
07/24/23	Zogenix Inc v. Apotex Inc 1:21-CV-01252 ( D. DE )	NOTICE requesting Clerk to remove Smitha B. Uthaman as co-counsel. Reason for request: no longer affiliated with the case. (Bilson, David) (Entered: 07/24/2023)
07/24/23	Zogenix Inc v. Apotex Inc 1:21-CV-01252 ( D. DE )	MOTION for Pro Hac Vice Appearance of Attorney Zhibin Li - filed by Lupin Ltd.. (Attachments: # 1 Certification of Zhibin Li)(Bilson, David) (Entered: 07/24/2023)
07/24/23	Zogenix Inc v. Apotex Inc 1:21-CV-01252 ( D. DE )	SO ORDERED, re 182 MOTION for Pro Hac Vice Appearance of Attorney Zhibin Li, filed by Lupin Ltd.. Signed by Judge Richard G. Andrews on 7/24/2023. (nms) (Entered: 07/24/2023)
07/21/23	Zogenix Inc v. Apotex Inc 1:21-CV-01252 ( D. DE )	DECLARATION of Olga Kalinina re 180 Redacted Document, by Apotex Corp., Apotex Inc.. (Hitch, Cortlan) Modified on 7/21/2023 (nms). (Entered: 07/21/2023)
07/21/23	Zogenix Inc v. Apotex Inc 1:21-CV-01252 ( D. DE )	REDACTED VERSION of 172 Response to Objections by Apotex Corp., Apotex Inc.. (Hitch, Cortlan) (Entered: 07/21/2023)
07/19/23	Zogenix Inc v. Apotex Inc 1:21-CV-01252 ( D. DE )	REDACTED VERSION of 168 Unopposed Motion to Seal the June 13, 2023 Hearing Transcript by Apotex Corp., Apotex Inc.. (Hitch, Cortlan) (Entered: 07/19/2023)
07/17/23	Zogenix Inc v. Apotex Inc 1:21-CV-01252 ( D. DE )	NOTICE OF SERVICE of (1) Opening Expert Report of Dr. William R. Roush Regarding Lupin Ltd.'s Infringement of U.S. Patent No. 10,947,183; (2) Opening Expert Report of Dr. Joseph Sullivan Regarding Lupin Ltd.'s Infringement of U.S. Patent Nos. 10,478,441; 10,478,442; and 11,406,606; (3) Opening Expert Report of Dr. James W. Wheless Regarding Objective Indicia of Nonobviousness Supporting the Validity of U.S. Patent Nos. 10,478,441 and 10,478,442; and (4) Opening Expert Report of Dr. George G. Zhanel Regarding Objective Indicia of Nonobviousness Supporting the Validity of U.S. Patent Nos. 10,478,441 and 10,478,442 filed by Katholieke Universiteit Leuven, University Hospital Antwerp, Zogenix International Ltd., Zogenix, Inc..(Dellinger, Megan) (Entered: 07/17/2023) NOTICE OF SERVICE of (1) Opening Expert Report of Dr. William R. Roush Regarding Lupin Ltd.'s Infringement of U.S. Patent No. 10,947,183; (2) Opening Expert Report of Dr. Joseph Sullivan Regarding Lupin Ltd.'s Infringement of U.S. Patent Nos. 10,478,441; 10,478,442; and 11,406,606; (3) Opening Expert Report of Dr. James W. Wheless Regarding Objective Indicia of Nonobviousness Supporting the Validity of U.S. Patent Nos. 10,478,441 and 10,478,442; and (4) Opening Expert Report of Dr. George G. Zhanel Regarding Objective Indicia of Nonobviousness Supporting the Validity of U.S. Patent Nos. 10,478,441 and 10,478,442 filed by Katholieke Universiteit Leuven, University Hospital Antwerp, Zogenix International Ltd., Zogenix, Inc..(Dellinger, Megan) (Entered: 07/17/2023)
07/17/23	Zogenix Inc v. Apotex Inc 1:21-CV-01252 ( D. DE )	NOTICE OF SERVICE of (1) Opening Expert Report of Dr. William R. Roush Regarding Apotex Inc. and Apotex Corp.'s Infringement of U.S. Patent Nos. 10,351,510 and 10,947,183; (2) Opening Expert Report of Dr. Joseph Sullivan Regarding Apotex Inc. and Apotex Corp.'s Infringement of U.S. Patent Nos. 10,478,441; 10,478,442; and 11,406,606; (3) Opening Expert Report of Dr. James W. Wheless Regarding Objective Indicia of Nonobviousness Supporting the Validity of U.S. Patent Nos. 10,478,441 and 10,478,442; (4) Opening Expert Report of Dr. George G. Zhanel Regarding Objective Indicia of Nonobviousness Supporting the Validity of U.S. Patent Nos. 10,478,441 and 10,478,442; and (5) Opening Expert Report of Dr. William R. Roush Regarding Objective Indicia of Nonobviousness Supporting the Validity of Claims 1, 28, and 29 of U.S. Patent No. 10,947,183 and Claims 1, 2, 4, 5, 8-12, and 16 of U.S. Patent No. 10,351,510 filed by Katholieke Universiteit Leuven, University Hospital Antwerp, Zogenix International Ltd., Zogenix, Inc..(Dellinger, Megan) (Entered: 07/17/2023) NOTICE OF SERVICE of (1) Opening Expert Report of Dr. William R. Roush Regarding Apotex Inc. and Apotex Corp.'s Infringement of U.S. Patent Nos. 10,351,510 and 10,947,183; (2) Opening Expert Report of Dr. Joseph Sullivan Regarding Apotex Inc. and Apotex Corp.'s Infringement of U.S. Patent Nos. 10,478,441; 10,478,442; and 11,406,606; (3) Opening Expert Report of Dr. James W. Wheless Regarding Objective Indicia of Nonobviousness Supporting the Validity of U.S. Patent Nos. 10,478,441 and 10,478,442; (4) Opening Expert Report of Dr. George G. Zhanel Regarding Objective Indicia of Nonobviousness Supporting the Validity of U.S. Patent Nos. 10,478,441 and 10,478,442; and (5) Opening Expert Report of Dr. William R. Roush Regarding Objective Indicia of Nonobviousness Supporting the Validity of Claims 1, 28, and 29 of U.S. Patent No. 10,947,183 and Claims 1, 2, 4, 5, 8-12, and 16 of U.S. Patent No. 10,351,510 filed by Katholieke Universiteit Leuven, University Hospital Antwerp, Zogenix International Ltd., Zogenix, Inc..(Dellinger, Megan) (Entered: 07/17/2023)